Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Short-term Investments (2019 - 2025)

Pulmonx has reported Short-term Investments over the past 6 years, most recently at $8.8 million for Q2 2025.

  • Quarterly Short-term Investments fell 82.85% to $8.8 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $8.8 million through Jun 2025, down 82.85% year-over-year, with the annual reading at $30.6 million for FY2024, 8.87% down from the prior year.
  • Short-term Investments was $8.8 million for Q2 2025 at Pulmonx, down from $14.1 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $51.1 million in Q2 2024 and troughed at $8.8 million in Q2 2025.
  • The 5-year median for Short-term Investments is $33.6 million (2023), against an average of $30.8 million.
  • Year-over-year, Short-term Investments surged 318.17% in 2022 and then crashed 82.85% in 2025.
  • A 5-year view of Short-term Investments shows it stood at $31.6 million in 2021, then increased by 24.84% to $39.4 million in 2022, then decreased by 14.84% to $33.6 million in 2023, then fell by 8.87% to $30.6 million in 2024, then tumbled by 71.35% to $8.8 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Short-term Investments are $8.8 million (Q2 2025), $14.1 million (Q1 2025), and $30.6 million (Q4 2024).